LSD, Reconsidered

First kisses, net neutrality, Bill Cunningham and more in our weekly look at the web

The strict ban on psychedelic substances has proved to be an obstacle for medical researchers, especially psychopharmacologists, but a recent paper published in The Journal of Nervous and Mental Disease shows that some are making headway. A team led by Swiss psychiatrist Peter Gasser conducted the first controlled trial of LSD in 40 years and concluded that the eight terminally ill patients who received full doses of LSD became less anxious.